Actively hiring
Rare Disease Therapeutics
Biologics & Biosimilars
Health Care
As featured in
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
News
What To Expect From Calliditas Therapeutics AB (OSTO:CALTX) Q3 2024 Earnings
At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.
Read more
Report
Critical Insights From Calliditas Therapeutics Analyst Ratings: What You Need To Know
In the last three months, 5 analysts have published ratings on Calliditas Therapeutics (NASDAQ:CALT), offering a diverse range of perspectives from bullish to bearish.The table below offers a condensed view of their recent ratings, showcasing the ...
Read more
Report
Asahi Kasei Makes $1.1B Offer For Swedish Drugmaker Calliditas Therapeutics, Enhancing Pharma Growth Strategy
Read more
Report
Calliditas Therapeutics Ab (publ) - CALT - Stock Price & News
Real time Calliditas Therapeutics Ab (publ) (CALT) stock price quote, stock graph, news & analysis.
Read more
Report
Calliditas Therapeutics to Host Key Opinion Leader Perspectives Webinar on the Pathophysiology and Treatment of IgA Nephropathy in Clinical Practice
--Calliditas Therapeutics AB today announced that it will host a Key Opinion Leader Perspectives webinar on the Pathophysiology and Treatment of IgA Nephropathy in Clinical Practice on Wednesday, March 10, 2021 at 10:00am Eastern Time.. The webinar will f
Read more
Report
